You are here
The content on this page and other TGA archive pages is provided to assist research and may contain references to activities or policies that have no current application. See the full archive disclaimer.
TGA business plan 2017-18
The TGA Business Plan 2017-18 provides an overview of our strategic priorities and activities including:
- Product regulation
- Regulatory reform
- International engagement
A full copy of the TGA Business Plan 2017-18 is also available for download in pdf format.
The Therapeutic Goods Administration (TGA) is part of the Health Products Regulation Group within the Department of Health. This Business Plan sets out our product regulation, regulatory reform and international engagement agenda for 2017-18 and the steps we will undertake to achieve our vision.
This document supplements the 2017-18 Health Portfolio Budget Statements and the Department of Health Corporate Plan 2017-18 and is supported by the Government's Regulator Performance Framework, the TGA Key Performance Indicators (KPIs), and the TGA International Strategy 2016-2020. Details are provided on how we will meet the Government's and the Australian public's expectations in relation to the regulation of therapeutic goods.
The TGA Business Plan is updated annually and is a central part of our activity planning and performance monitoring framework.
Our vision is:
Better health and wellbeing for all Australians through regulatory excellence.
This links directly with the Department of Health vision:
Better health and wellbeing for all Australians now and for future generations.
We protect the health and safety of the community by regulating therapeutic goods. We strive for regulatory excellence by focussing on our:
- Purpose - who we are and what we do
- Principles - how we will conduct ourselves
- Priorities - what we will focus on.